May 2025 in Pharmacology: Key Trends, Challenges and Prospects
In May 2025, the pharmaceutical industry in Ukraine and the world demonstrated dynamic changes at both the regulatory and scientific levels. Below is an overview of the main events that determine the vector of the industry’s development in the medium term.
📈 Growth of the Ukrainian pharmacy market
According to the results of May 2025, there was a significant increase in sales volumes of medicines:
- +19.4% in hryvnia terms
- +14.2% in dollar terms
- +0.9% in physical terms (number of packages)
The share of prescription drugs and dietary supplements increased in particular. The most dynamic growth was shown by drugs for the treatment of diabetes mellitus (group A10), which indicates the relevance of the topic of metabolic disorders in the structure of morbidity.
⚖️ Regulatory changes: new pricing rules
The implementation of Law No. 4239 has activated a profound transformation of pricing mechanisms in the pharmaceutical market. In particular:
- A National Catalog of Drug Prices has been introduced, which is updated monthly;
- the principle of referencing applies: the maximum price should not exceed the average of the three lowest among the referent countries;
- Marketing activity of manufacturers and distributors is limited.
The new model is expected to increase transparency, competition, and reduce economic pressure on patients.
🧬 Scientific achievements and innovative developments
On the world stage, in May 2025, the results of a number of promising clinical studies were published:
- DLX-159 is a new generation psychoplastogen for the treatment of depression that does not cause hallucinations.
- 5-MeO-DMT is a fast-acting psychedelic in the treatment of resistant depression.
- Pacibekitug is an IL-6 antibody with potential for treating chronic inflammation.
- CVN‑424 (Solangepras) is a promising drug for the treatment of Parkinson’s disease, which is undergoing phase 3 studies.
- Suzetrigine (NaV1.8 inhibitor) is a new approach to opioid-free pain relief approved by the FDA.
These developments confirm the general trend in pharmaceutical science: a shift in focus from symptomatic treatment to pathogenetic and personalized therapy.
🧠 The role of innovation: artificial intelligence and bioanalytics
Pharmacological research actively integrates the latest analytical platforms:
- POINT is a multiomic system for analyzing drug interactions.
- Explainable AI (XAI) combined with Quantitative Systems Pharmacology (QSP) methods to accurately model the body’s response to treatment.
This opens up new horizons for personalized prediction of drug efficacy and safety.
🔎 Conclusions
- The Ukrainian pharmaceutical market demonstrates resilience and a growth trend despite macroeconomic challenges.
- Regulatory innovations create the prerequisites for the formation of a transparent, competitive, and socially responsible system of access to medicines.
- Global scientific breakthroughs signal the transition to a new era in medicine — with a focus on neuropsychiatric conditions, immunomodulation, and personalized therapy.
- The integration of artificial intelligence and bioinformatics technologies is already changing the approach to pharmacological prediction.
The material was prepared based on publications from leading Ukrainian and international specialized sources.
For a detailed analysis, you can refer to official reports from the forums “Pharmacies of the World 2025”, “FarmExpert 2025”, the FDA database, and scientific publications in PubMed.
